R. Čapek

986 total citations
51 papers, 788 citations indexed

About

R. Čapek is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, R. Čapek has authored 51 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 13 papers in Psychiatry and Mental health and 12 papers in Molecular Biology. Recurrent topics in R. Čapek's work include Neuroscience and Neuropharmacology Research (22 papers), Pain Mechanisms and Treatments (9 papers) and Ion channel regulation and function (8 papers). R. Čapek is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Pain Mechanisms and Treatments (9 papers) and Ion channel regulation and function (8 papers). R. Čapek collaborates with scholars based in Canada, Czechia and United States. R. Čapek's co-authors include B. Esplin, Yves De Koninck, Michael Jackson, Michał Abrahamowicz, Robyn Tamblyn, V. Bauer, Don W. Esplin, Martín G. Cole, Ling Han and Jane McCusker and has published in prestigious journals such as Journal of Neurophysiology, Brain Research and Neuroscience.

In The Last Decade

R. Čapek

50 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Čapek Canada 17 403 261 180 102 91 51 788
Jeremy R.M. Haigh United Kingdom 14 458 1.1× 176 0.7× 140 0.8× 151 1.5× 58 0.6× 24 894
Leon Karp Israel 18 336 0.8× 172 0.7× 300 1.7× 130 1.3× 48 0.5× 27 940
Hiroshi Suwaki Japan 19 400 1.0× 326 1.2× 190 1.1× 67 0.7× 94 1.0× 85 1.1k
Yoshio Morita Japan 17 248 0.6× 211 0.8× 136 0.8× 133 1.3× 121 1.3× 58 733
E. Tempesta Italy 18 342 0.8× 178 0.7× 104 0.6× 157 1.5× 105 1.2× 49 1.1k
Joseph C. Schoolar United States 16 266 0.7× 153 0.6× 253 1.4× 153 1.5× 72 0.8× 41 873
B. D. Kantamaneni United Kingdom 21 419 1.0× 171 0.7× 152 0.8× 105 1.0× 165 1.8× 31 1.0k
Jamie Barnhill United States 15 347 0.9× 171 0.7× 126 0.7× 167 1.6× 38 0.4× 25 870
Rolf Axelsson Sweden 14 233 0.6× 237 0.9× 281 1.6× 59 0.6× 107 1.2× 31 780
B M Cohen United States 14 322 0.8× 241 0.9× 415 2.3× 150 1.5× 195 2.1× 17 1.0k

Countries citing papers authored by R. Čapek

Since Specialization
Citations

This map shows the geographic impact of R. Čapek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Čapek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Čapek more than expected).

Fields of papers citing papers by R. Čapek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Čapek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Čapek. The network helps show where R. Čapek may publish in the future.

Co-authorship network of co-authors of R. Čapek

This figure shows the co-authorship network connecting the top 25 collaborators of R. Čapek. A scholar is included among the top collaborators of R. Čapek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Čapek. R. Čapek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McLeod, Peter J., et al.. (2012). Peer review: An effective approach to cultivating lecturing virtuosity. Medical Teacher. 35(4). e1046–e1051. 14 indexed citations
2.
Han, Ling, Jane McCusker, Martín G. Cole, R. Čapek, & Michał Abrahamowicz. (2011). Antidepressant Use and Cognitive Functioning in Older Medical Patients With Major or Minor Depression. Journal of Clinical Psychopharmacology. 31(4). 429–435. 16 indexed citations
3.
Han, Ling, Jane McCusker, Martín G. Cole, Michał Abrahamowicz, & R. Čapek. (2008). 12-Month Cognitive Outcomes of Major and Minor Depression in Older Medical Patients. American Journal of Geriatric Psychiatry. 16(9). 742–751. 26 indexed citations
4.
Han, Ling, Jane McCusker, Michał Abrahamowicz, Martín G. Cole, & R. Čapek. (2006). The Temporal Relationship Between Depression Symptoms and Cognitive Functioning in Older Medical Patients--Prospective or Concurrent?. The Journals of Gerontology Series A. 61(12). 1319–1323. 21 indexed citations
5.
Bartlett, Gillian, Michał Abrahamowicz, Robyn Tamblyn, et al.. (2003). Longitudinal patterns of new Benzodiazepine use in the elderly. Pharmacoepidemiology and Drug Safety. 13(10). 669–682. 44 indexed citations
6.
Jackson, Michael, B. Esplin, & R. Čapek. (2000). Reversal of the activity-dependent suppression of GABA-mediated inhibition in hippocampal slices from γ-vinyl GABA (vigabatrin)-pretreated rats. Neuropharmacology. 39(1). 65–74. 30 indexed citations
8.
Jackson, Michael, B. Esplin, & R. Čapek. (1999). Activity-dependent enhancement of hyperpolarizing and depolarizing γ-aminobutyric acid (GABA) synaptic responses following inhibition of GABA uptake by tiagabine. Epilepsy Research. 37(1). 25–36. 24 indexed citations
9.
McLeod, Peter J., A. Claudio Cuello, R. Čapek, & Billie J. Collier. (1996). A multidimensional evaluation system in a basic science course in medicine. Medical Teacher. 18(1). 19–22. 7 indexed citations
10.
Jackson, Michael, Trevor Dennis, B. Esplin, & R. Čapek. (1994). Acute effects of γ-vinyl GABA (vigabatrin) on hippocampal GABAergic inhibition in vitro. Brain Research. 651(1-2). 85–91. 21 indexed citations
11.
Clarke, Paul B. S., Isabelle Chaudieu, H. El‐Bizri, et al.. (1994). The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. British Journal of Pharmacology. 111(2). 397–405. 62 indexed citations
12.
Čapek, R. & B. Esplin. (1994). Effects of lidocaine on hippocampal pyramidal cells. Neuroreport. 5(6). 681–684. 7 indexed citations
13.
Čapek, R. & B. Esplin. (1993). Frequency-dependent enhancement of hippocampal inhibition by GABA uptake blockers. Epilepsy Research. 16(2). 123–130. 8 indexed citations
14.
McLeod, Peter J., A. Claudio Cuello, R. Čapek, & Billie J. Collier. (1992). A tutorial/essay project to expand the learning experience in undergraduate medical pharmacology. Medical Teacher. 14(4). 343–346. 4 indexed citations
15.
Čapek, R. & B. Esplin. (1991). Attenuation of hippocampal inhibition by a NMDA () receptor antagonist. Neuroscience Letters. 129(1). 145–148. 10 indexed citations
16.
Zorychta, Edith & R. Čapek. (1978). Depression of spinal monosynaptic transmission by diethyl ether: quantal analysis of unitary synaptic potentials.. Journal of Pharmacology and Experimental Therapeutics. 207(3). 825–836. 20 indexed citations
17.
Esplin, B. & R. Čapek. (1976). Quantitative characterization of THC and ethanol interaction.. PubMed. 15(1). 199–202. 3 indexed citations
18.
Bauer, V. & R. Čapek. (1972). Studies on the neuropharmacology of papaverine —III. The inhibition of ganglionic transmission. Neuropharmacology. 11(5). 697–701. 11 indexed citations
19.
Kadlec, O & R. Čapek. (1969). Staphylococcal alpha toxin induced ionic transport and permeability changes in frog skin. Biochemical Pharmacology. 18(7). 1775–1777. 2 indexed citations
20.
Čapek, R., K. Mašek, M Srámka, M Kršiak, & P Svec. (1969). The Similarities of the Angiotensin and Bradykinin Action on the Central Nervous System. Pharmacology. 2(3). 161–170. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026